Restructuring of a pharma stock

PharmaDeep value buy yields protected gains

The company under consideration bought several special medication companies and patents but financed the business with too much credit. First as a result of hiking prices the stock price exploded. A collaps followed that reduced the stock price well below replacement costs. The CEO was replaced as well as the CFO and the company is steering into the right direction again. Extreme moves enabled GAMAG Black+White to implement various profitable short option positions, a way of participation at a further discounted price level and thus further reduced risk. GAMAG Black+White uses option strategies extensively to reduce and mitigate risks.